Staphylococcus aureus Virulence — how the Alpha Hemolysin Damages the Host
Abstract & Commentary
Staphylococcus aureus Virulence — how the Alpha Hemolysin Damages the Host
By Dean L. Winslow, MD, FACP, FIDSA, Chairman, Department of Medicine, Santa Clara Valley, Medical Center; Clinical Professor, Stanford University School of Medicine, is Associate Editor for Infectious Disease Alert.
Dr. Winslow is a consultant for Siemens Diagnostic.
Synopsis: Staphylococcal a-hemolysin (Hla) is a major virulence factor in S.aureus pneumonia. It activates the nucleotide-binding domain and leucine-rich repeat containing gene family, pyrin domain containing 3 (NLRP3) inflammasome inducing production of IL-1B and programmed cell death.
Source: Kebaier C, et al. Staphylococcus aureus a-hemolysin mediates virulence in a murine model of severe pneumonia through activation of the NLRP3 inflammasome. Jrl Infect Dis 2012; 205(5): 807-17.
A wild type Newman strain of S.aureus and the hemolysin-deficient Newman strain hla::erm were studied in wild-type mice and Nlrp3-/- and IL1r1-/- mice. In addition, pyrogen-free purified hemolysin was used in several intratracheal challenge experiments. An established murine pneumonia model was employed using viable S. aureus, heat-killed S.aureus (HKSA) or hemolysin. Bronchoalveolar lavage (BAL) with determination of cell counts in BAL fluid, lung mechanics and histology were all assessed.
Heat-killed S. aureus, Hla, and HKSA+Hla did not induce IL-1 secretion in Nlrp3-/- mice. In contrast, Hla with or without HKSA induced high levels of IL-1 in wild type, but not in Nlrp3-/- mice. In a similar fashion, the histology of lungs in wild type mice challenged with HKSA+Hla showed marked neutrophil infiltration, vasculitis, vascular extravasation, epithelial sloughing and necrosis whereas histopathologic changes seen in similarly-challenged Nlrp3-/- mice were minimal. At 60 hours 80% of challenged Nlrp3-/- mice survived compared to only 30% of wild type mice.
In mice challenged with live S. aureus wild type Newman strain, mortality was higher in the wild type mice than it was in the Nlrp3-/- mice. Pulmonary function abnormalities were more severe in wild type surviving mice treated with vancomycin than observed in Nlrp3-/- mice. These differential effects were not related to S. aureus burden since S. aureus CFU/mL in BAL fluid were the same in wild type and Nlrp3-/- mice. As in the studies done with HKSA and HKSA+Hla, mortality and histopathological abnormalities were correlated with IL-1 and neutrophil levels in BAL fluid, but not with TNF in BAL fluid.
In mice challenged with hemolysin-deficient S. aureus there were no differences in neutrophil counts in BAL fluid in wild type vs. NLRP3-/- mice. In IL1r1-/- mice challenged with live S. aureus mortality was indistinguishable from that seen in wild type mice. Finally, experiments in CD11b+ cells, hemolysin induced NLRP3-dependent programmed necrosis in these cells as shown by release of the marker HMGB1.
Commentary
All S.aureus produce secreted exotoxins including the cytolysins a-hemolysin, hemolysin, and bicomponent leukocidins.1 Moreover, a-hemolysin has emerged as a key virulence factor in a murine model of S. aureus necrotizing pneumonia.2 Purified hemolysin has also been shown to induce pulmonary inflammation in rats and rabbits.3-5
The NLRP3 inflammasome is signaling complex which activates procaspase-1, processing and secretion of IL-1B and IL-18, and the initiation of programmed cell necrosis. The NLRP3 inflammasome is activated in response to a number of pathogen-derived molecules and S. aureus hemolysin has recently been shown to induce NLRP3-mediated signaling in cultured cells.6
The elegant studies reported in this paper conclusively demonstrate that hemolysin almost certainly causes pulmonary damage through activation of NLRP3 inflammasome-mediated signaling and that this effect is independent of IL-1 expression. While mice lacking NLRP3 are not completely protected from hemolysin-producing S. aureus this suggests that hemolysin promotes virulence through both NLRP3-dependent and NLRP3-independent mechanisms. The authors postulate that targeting the NLRP3 inflammasome might someday be a potential therapeutic strategy in not only S. aureus pneumonia, but also in bacterial pneumonias due to other pathogens including Streptococcus pneumoniae in which pore-forming toxins including pneumolysin have also been shown to activate NLRP3 signaling.
References
- Diep BA, et al. The role of virulence determinants in community-associated MRSA pathogenesis. Trends Microbiol 2008;16: 361-9.
- Bubock-Wardenburg J, et al. Surface and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect Immun 2007; 75:1040-4.
- McElroy MC, et al. Alpha-toxin damages the air-blood barrier of the lung in a rat model of Staphylococcus aureus-induced pneumonia. Infect Immun 1999; 67: 5541-4.
- Seeger W, et al. Staphylococcal alpha-toxin-induced vascular leakage in isolated perfused rabbit lungs. Lab Invest 1990; 63: 341-9.
- Seeger W, et al. Staphylococcal alpha-toxin elicits hypertension in isolated rabbit lungs. Evidence for thromboxane formation and the role of extracellular calcium. J Clin Invest 1984; 74: 849-58.
- Craven RR, et al. Staphylococcus aureus alpha-toxin activates the NLRP3-inflammasome in human and mouse monocytic cells. PLoS One 2009;4:e7446
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.